Search Results : HIV

604 interactions found:

Novel Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
transmembrane protein 115
Pathway 1
Pathway 2
  • COPI-mediated anterograde transport
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
reticulophagy regulator family member 3
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
solute carrier family 10 member 6
Pathway 1
Pathway 2
  • SLC-mediated bile acid transport
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
phosphatidylinositol transfer protein cytoplasmic 1
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
receptor accessory protein 4
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
jagunal vesicle mediated transporter 1
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
fat storage inducing transmembrane protein 2
Pathway 1
Pathway 2
  • Lipid particle organization
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
hydroxysteroid 17-beta dehydrogenase 11
Pathway 1
Pathway 2
  • Estrogen biosynthesis
Drugs 1
  • Polyethylene glycol 400
Drugs 2
  • Aetiocholanolone
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
thioredoxin related transmembrane protein 2
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
FKBP prolyl isomerase 7
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
acyl-CoA synthetase long chain family member 4
Name2
HIV-1 Tat interactive protein 2
Pathway 1
  • Intracellular metabolism of fatty acids regulates insulin secretion
  • Synthesis of very long-chain fatty acyl-CoAs
Pathway 2
Drugs 1
  • Icosapent
  • Troglitazone
  • Rosiglitazone
Drugs 2
  • Polyethylene glycol 400
Diseases 1
  • Non-syndromic X-linked mental retardation
Diseases 2
Novel
Novel
Name 1
perilipin 2
Name2
HIV-1 Tat interactive protein 2
Pathway 1
  • PPARA activates gene expression
  • Lipophagy
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
Pathway 2
Drugs 1
Drugs 2
  • Polyethylene glycol 400
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
carboxypeptidase N subunit 1
Name2
carboxypeptidase N subunit 2
Pathway 1
  • Regulation of Complement cascade
Pathway 2
  • Regulation of Complement cascade
Drugs 1
  • Zinc
  • ORE-1001
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
Drugs 2
  • Zinc
  • ORE-1001
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
adenylate cyclase 8
Name2
calmodulin 2
Pathway 1
  • Glucagon signaling in metabolic regulation
  • PKA activation
  • PKA activation in glucagon signalling
  • Adenylate cyclase activating pathway
  • Adenylate cyclase inhibitory pathway
  • Adenylate cyclase inhibitory pathway
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • G alpha (s) signalling events
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • G alpha (z) signalling events
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • CREB1 phosphorylation through the activation of Adenylate Cyclase
  • Hedgehog 'off' state
  • GPER1 signaling
  • GPER1 signaling
  • ADORA2B mediated anti-inflammatory cytokines production
  • ADORA2B mediated anti-inflammatory cytokines production
  • FCGR3A-mediated IL10 synthesis
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
Pathway 2
  • CaMK IV-mediated phosphorylation of CREB
  • CaMK IV-mediated phosphorylation of CREB
  • Calmodulin induced events
  • Cam-PDE 1 activation
  • CaM pathway
  • Platelet degranulation
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • PKA activation
  • DARPP-32 events
  • Synthesis of IP3 and IP4 in the cytosol
  • Calcineurin activates NFAT
  • Calcineurin activates NFAT
  • eNOS activation
  • Transcriptional activation of mitochondrial biogenesis
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Stimuli-sensing channels
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • Ca2+ pathway
  • Reduction of cytosolic Ca++ levels
  • Sodium/Calcium exchangers
  • Unblocking of NMDA receptors, glutamate binding and activation
  • CREB1 phosphorylation through the activation of Adenylate Cyclase
  • CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
  • CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
  • Ras activation upon Ca2+ influx through NMDA receptor
  • Smooth Muscle Contraction
  • Smooth Muscle Contraction
  • Activation of Ca-permeable Kainate Receptor
  • Uptake and function of anthrax toxins
  • VEGFR2 mediated vascular permeability
  • VEGFR2 mediated cell proliferation
  • Phase 0 - rapid depolarisation
  • Ion homeostasis
  • CLEC7A (Dectin-1) induces NFAT activation
  • CLEC7A (Dectin-1) induces NFAT activation
  • RHO GTPases activate IQGAPs
  • RHO GTPases activate PAKs
  • RHO GTPases activate PAKs
  • RAF activation
  • RAF/MAP kinase cascade
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by BRAF and RAF1 fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Glycogen breakdown (glycogenolysis)
  • Glycogen breakdown (glycogenolysis)
  • Protein methylation
  • Extra-nuclear estrogen signaling
  • Loss of phosphorylation of MECP2 at T308
  • Regulation of MECP2 expression and activity
  • Ion transport by P-type ATPases
  • Negative regulation of NMDA receptor-mediated neuronal transmission
  • Activation of RAC1 downstream of NMDARs
  • Activation of RAC1 downstream of NMDARs
  • Activation of AMPK downstream of NMDARs
  • Long-term potentiation
  • Long-term potentiation
  • RAS processing
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • FCGR3A-mediated IL10 synthesis
  • FCGR3A-mediated IL10 synthesis
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
  • CASP4 inflammasome assembly
  • Microbial factors inhibit CASP4 activity
  • CASP4 inflammasome assembly
  • Microbial factors inhibit CASP4 activity
  • CASP4 inflammasome assembly
  • Microbial factors inhibit CASP4 activity
Drugs 1
  • Colforsin
Drugs 2
  • Chlorpromazine
  • Cinchocaine
  • Nicardipine
  • Fluphenazine
  • Isoflurane
  • Trifluoperazine
  • Loperamide
  • Perphenazine
  • Phenoxybenzamine
  • Felodipine
  • Melatonin
  • Promethazine
  • Pimozide
  • Nifedipine
  • Bepridil
  • Calcium
  • Aprindine
  • Deacetoxyvinzolidine
  • tert-butanol
  • Trimethyllysine
  • Dequalinium
  • N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide
  • Prenylamine
  • Flunarizine
  • (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE
  • Myristic acid
  • Calcium citrate
  • Calcium citrate
  • Calcium citrate
  • Calcium Phosphate
  • Calcium Phosphate
  • Calcium Phosphate
  • Calcium levulinate
  • Calcium phosphate dihydrate
  • Calcium phosphate dihydrate
  • Calcium phosphate dihydrate
Diseases 1
Diseases 2
Novel
Novel
Name 1
piwi like RNA-mediated gene silencing 1
Name2
dicer 1, ribonuclease III
Pathway 1
  • PIWI-interacting RNA (piRNA) biogenesis
Pathway 2
  • MicroRNA (miRNA) biogenesis
  • Small interfering RNA (siRNA) biogenesis
  • tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis
  • tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis
  • M-decay: degradation of maternal mRNAs by maternally stored factors
  • Regulation of MITF-M-dependent genes involved in apoptosis
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
RNA, U6 small nuclear 1
Name2
RNA binding motif protein 22
Pathway 1
Pathway 2
  • mRNA Splicing - Major Pathway
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
plexin A2
Name2
cell migration inducing hyaluronidase 1
Pathway 1
  • Sema3A PAK dependent Axon repulsion
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • CRMPs in Sema3A signaling
  • CRMPs in Sema3A signaling
  • Other semaphorin interactions
Pathway 2
  • Hyaluronan degradation
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
microtubule associated protein 1 light chain 3 alpha
Name2
transmembrane protein 132C
Pathway 1
  • Macroautophagy
  • PINK1-PRKN Mediated Mitophagy
  • Receptor Mediated Mitophagy
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
glucagon like peptide 1 receptor
Name2
cornichon family member 4
Pathway 1
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • G alpha (s) signalling events
  • Glucagon-type ligand receptors
Pathway 2
Drugs 1
  • Glucagon
  • Exenatide
  • Liraglutide
  • Albiglutide
  • Dulaglutide
  • Lixisenatide
  • Semaglutide
  • Taspoglutide
  • Tirzepatide
  • Efpeglenatide
  • Glutazumab
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
glucagon like peptide 1 receptor
Name2
UDP glucuronosyltransferase family 1 member A9
Pathway 1
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • G alpha (s) signalling events
  • Glucagon-type ligand receptors
Pathway 2
  • Glucuronidation
  • PPARA activates gene expression
  • Aspirin ADME
  • Paracetamol ADME
Drugs 1
  • Glucagon
  • Exenatide
  • Liraglutide
  • Albiglutide
  • Dulaglutide
  • Lixisenatide
  • Semaglutide
  • Taspoglutide
  • Tirzepatide
  • Efpeglenatide
  • Glutazumab
Drugs 2
  • Niflumic acid
  • Phenolphthalein
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
transmembrane protein 115
Pathway 1
Pathway 2
  • COPI-mediated anterograde transport
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
reticulophagy regulator family member 3
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
solute carrier family 10 member 6
Pathway 1
Pathway 2
  • SLC-mediated bile acid transport
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
phosphatidylinositol transfer protein cytoplasmic 1
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
receptor accessory protein 4
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
jagunal vesicle mediated transporter 1
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
fat storage inducing transmembrane protein 2
Pathway 1
Pathway 2
  • Lipid particle organization
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
hydroxysteroid 17-beta dehydrogenase 11
Pathway 1
Pathway 2
  • Estrogen biosynthesis
Drugs 1
  • Polyethylene glycol 400
Drugs 2
  • Aetiocholanolone
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
thioredoxin related transmembrane protein 2
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
FKBP prolyl isomerase 7
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
acyl-CoA synthetase long chain family member 4
Name2
HIV-1 Tat interactive protein 2
Pathway 1
  • Intracellular metabolism of fatty acids regulates insulin secretion
  • Synthesis of very long-chain fatty acyl-CoAs
Pathway 2
Drugs 1
  • Icosapent
  • Troglitazone
  • Rosiglitazone
Drugs 2
  • Polyethylene glycol 400
Diseases 1
  • Non-syndromic X-linked mental retardation
Diseases 2
Novel
Name 1
perilipin 2
Name2
HIV-1 Tat interactive protein 2
Pathway 1
  • PPARA activates gene expression
  • Lipophagy
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
Pathway 2
Drugs 1
Drugs 2
  • Polyethylene glycol 400
Diseases 1
Diseases 2
Novel
Symbols
Name 1
carboxypeptidase N subunit 1
Name2
carboxypeptidase N subunit 2
Pathway 1
  • Regulation of Complement cascade
Pathway 2
  • Regulation of Complement cascade
Drugs 1
  • Zinc
  • ORE-1001
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
Drugs 2
  • Zinc
  • ORE-1001
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
Diseases 1
Diseases 2
Novel
Symbols
Name 1
adenylate cyclase 8
Name2
calmodulin 2
Pathway 1
  • Glucagon signaling in metabolic regulation
  • PKA activation
  • PKA activation in glucagon signalling
  • Adenylate cyclase activating pathway
  • Adenylate cyclase inhibitory pathway
  • Adenylate cyclase inhibitory pathway
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • G alpha (s) signalling events
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • G alpha (z) signalling events
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • CREB1 phosphorylation through the activation of Adenylate Cyclase
  • Hedgehog 'off' state
  • GPER1 signaling
  • GPER1 signaling
  • ADORA2B mediated anti-inflammatory cytokines production
  • ADORA2B mediated anti-inflammatory cytokines production
  • FCGR3A-mediated IL10 synthesis
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
Pathway 2
  • CaMK IV-mediated phosphorylation of CREB
  • CaMK IV-mediated phosphorylation of CREB
  • Calmodulin induced events
  • Cam-PDE 1 activation
  • CaM pathway
  • Platelet degranulation
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • PKA activation
  • DARPP-32 events
  • Synthesis of IP3 and IP4 in the cytosol
  • Calcineurin activates NFAT
  • Calcineurin activates NFAT
  • eNOS activation
  • Transcriptional activation of mitochondrial biogenesis
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Stimuli-sensing channels
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • Ca2+ pathway
  • Reduction of cytosolic Ca++ levels
  • Sodium/Calcium exchangers
  • Unblocking of NMDA receptors, glutamate binding and activation
  • CREB1 phosphorylation through the activation of Adenylate Cyclase
  • CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
  • CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
  • Ras activation upon Ca2+ influx through NMDA receptor
  • Smooth Muscle Contraction
  • Smooth Muscle Contraction
  • Activation of Ca-permeable Kainate Receptor
  • Uptake and function of anthrax toxins
  • VEGFR2 mediated vascular permeability
  • VEGFR2 mediated cell proliferation
  • Phase 0 - rapid depolarisation
  • Ion homeostasis
  • CLEC7A (Dectin-1) induces NFAT activation
  • CLEC7A (Dectin-1) induces NFAT activation
  • RHO GTPases activate IQGAPs
  • RHO GTPases activate PAKs
  • RHO GTPases activate PAKs
  • RAF activation
  • RAF/MAP kinase cascade
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by BRAF and RAF1 fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Glycogen breakdown (glycogenolysis)
  • Glycogen breakdown (glycogenolysis)
  • Protein methylation
  • Extra-nuclear estrogen signaling
  • Loss of phosphorylation of MECP2 at T308
  • Regulation of MECP2 expression and activity
  • Ion transport by P-type ATPases
  • Negative regulation of NMDA receptor-mediated neuronal transmission
  • Activation of RAC1 downstream of NMDARs
  • Activation of RAC1 downstream of NMDARs
  • Activation of AMPK downstream of NMDARs
  • Long-term potentiation
  • Long-term potentiation
  • RAS processing
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • FCGR3A-mediated IL10 synthesis
  • FCGR3A-mediated IL10 synthesis
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
  • CASP4 inflammasome assembly
  • Microbial factors inhibit CASP4 activity
  • CASP4 inflammasome assembly
  • Microbial factors inhibit CASP4 activity
  • CASP4 inflammasome assembly
  • Microbial factors inhibit CASP4 activity
Drugs 1
  • Colforsin
Drugs 2
  • Chlorpromazine
  • Cinchocaine
  • Nicardipine
  • Fluphenazine
  • Isoflurane
  • Trifluoperazine
  • Loperamide
  • Perphenazine
  • Phenoxybenzamine
  • Felodipine
  • Melatonin
  • Promethazine
  • Pimozide
  • Nifedipine
  • Bepridil
  • Calcium
  • Aprindine
  • Deacetoxyvinzolidine
  • tert-butanol
  • Trimethyllysine
  • Dequalinium
  • N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide
  • Prenylamine
  • Flunarizine
  • (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE
  • Myristic acid
  • Calcium citrate
  • Calcium citrate
  • Calcium citrate
  • Calcium Phosphate
  • Calcium Phosphate
  • Calcium Phosphate
  • Calcium levulinate
  • Calcium phosphate dihydrate
  • Calcium phosphate dihydrate
  • Calcium phosphate dihydrate
Diseases 1
Diseases 2
Novel
Name 1
piwi like RNA-mediated gene silencing 1
Name2
dicer 1, ribonuclease III
Pathway 1
  • PIWI-interacting RNA (piRNA) biogenesis
Pathway 2
  • MicroRNA (miRNA) biogenesis
  • Small interfering RNA (siRNA) biogenesis
  • tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis
  • tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis
  • M-decay: degradation of maternal mRNAs by maternally stored factors
  • Regulation of MITF-M-dependent genes involved in apoptosis
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
RNA, U6 small nuclear 1
Name2
RNA binding motif protein 22
Pathway 1
Pathway 2
  • mRNA Splicing - Major Pathway
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
plexin A2
Name2
cell migration inducing hyaluronidase 1
Pathway 1
  • Sema3A PAK dependent Axon repulsion
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • CRMPs in Sema3A signaling
  • CRMPs in Sema3A signaling
  • Other semaphorin interactions
Pathway 2
  • Hyaluronan degradation
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
microtubule associated protein 1 light chain 3 alpha
Name2
transmembrane protein 132C
Pathway 1
  • Macroautophagy
  • PINK1-PRKN Mediated Mitophagy
  • Receptor Mediated Mitophagy
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
glucagon like peptide 1 receptor
Name2
cornichon family member 4
Pathway 1
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • G alpha (s) signalling events
  • Glucagon-type ligand receptors
Pathway 2
Drugs 1
  • Glucagon
  • Exenatide
  • Liraglutide
  • Albiglutide
  • Dulaglutide
  • Lixisenatide
  • Semaglutide
  • Taspoglutide
  • Tirzepatide
  • Efpeglenatide
  • Glutazumab
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
glucagon like peptide 1 receptor
Name2
UDP glucuronosyltransferase family 1 member A9
Pathway 1
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • G alpha (s) signalling events
  • Glucagon-type ligand receptors
Pathway 2
  • Glucuronidation
  • PPARA activates gene expression
  • Aspirin ADME
  • Paracetamol ADME
Drugs 1
  • Glucagon
  • Exenatide
  • Liraglutide
  • Albiglutide
  • Dulaglutide
  • Lixisenatide
  • Semaglutide
  • Taspoglutide
  • Tirzepatide
  • Efpeglenatide
  • Glutazumab
Drugs 2
  • Niflumic acid
  • Phenolphthalein
Diseases 1
Diseases 2

Page 29 out of 31 pages

© Madhavi K. Ganapathiraju 2012-2025